Teramoto · Journal of science and medicine in sport 2010 · literature review of epidemiological studies · n=14 studies

Mortality and longevity of elite athletes.

Cited 160 times in the scientific literature.

Level 3 - non-randomized controlled study

Literature review synthesizing observational epidemiological cohort studies

PubMed 19574095 · doi:10.1016/j.jsams.2009.04.010 · record verified 2026-08-26

What was done

Authors reviewed 14 epidemiological studies to evaluate the association between elite competitive sports participation and mortality or longevity. Identified articles were classified by sport category (endurance/aerobic, mixed aerobic/anaerobic, and power/anaerobic). Extracted outcomes included life expectancy, standardised mortality ratios, standardised proportionate mortality ratios, mortality rates, and mortality odds ratios for all causes of death compared to the general population.

What was found

The abstract provides qualitative directions of effect without reporting quantitative figures, confidence intervals, or pooled effect estimates. Elite endurance athletes and mixed-sports athletes had lower overall mortality and greater longevity than the general population, with reduced cardiovascular disease mortality noted as the likely primary factor. Power athletes showed inconsistent mortality findings across studies. Across all sport categories combined, elite athlete mortality was lower than that of the general population.

Why it matters

This synthesis demonstrates that vigorous, long-term athletic training is generally linked to improved survival rather than cardiac harm, though benefits vary by athletic discipline.

Limits

The abstract provides no numerical data, hazard ratios, or formal meta-analytic pooling. The primary literature relies on observational cohort designs subject to healthy performer bias, socioeconomic confounding, and unmeasured post-career lifestyle factors. Results for power athletes remain conflicting.

Cited by